LUPUS ERYTHEMATOSUS – Umbilical cord-derived allogeneic mesenchymal stem cell grafts – Recruitment is open. Request for a major protocol modification is underway to allow Covid+ LES patients access to this innovative therapy

Allogeneic mesenchymal stem cell grafts (IV injection) in severe Lupus Erythematosus refractory to standard therapies. Identifiant ClinicalTrials.gov : NCT03562065 Financement

Read more

SYSTEMIC SCLEROSIS – NISSC-2 non-interventional study – Autologous Hematopoietic Stem Cell Transplantation – Active recruiting continues during period of COVID-19 pandemic for transplanted patients/all patient follow-ups conducted through telemedicine

ClinicalTrials.gov: NCT03444805 Protocol Title: Post AHSCT (Autologous Hematopoietic Stem Cell Transplantation) management for patients with systemic sclerosis: a prospective, non-interventional

Read more

Neuromyelitis Optica (NMO) and NMO spectrum disorders : NISMO (EBMT) – Autologous Hematopoietic Stem Cell Transplantation – Active recruiting continues during period of COVID-19 pandemic for transplanted patients/all patient follow-ups conducted through telemedicine

Protocol Title : Autologous Hematopoietic Stem Cell Transplantation for Neuromyelitis Optica (NMO) and NMO spectrum disorders : a Prospective Non-Interventional

Read more